Mardi 13 mai 2025: Lorelei Ana Garagancea
Lorelei Ana Garagancea soutiendra, en vue de l'obtention du grade de docteure en droit, sa thèse intitulée:
« Use of Licensing to Enhance Access to Affordable Medicines »
Mardi 13 mai 2025 – 14h15
Salle 3050 - UNI MAIL
Jury : Prof. Ruth L. OKEDIJI, Jeremiah Smith, Jr. Professor of Law, Harvard Law School, USA, M. Antony TAUBMAN, ancien directeur de la Division sur la Propriété intellectuelle, OMC, Prof. Jacques DE WERRA, Prof. honoraire Gabrielle MARCEAU (directrice de thèse), sous la présidence du Prof. Luc THÉVENOZ, doyen de la Faculté de droit.
Résumé:
The thesis analyses voluntary and compulsory licences from the perspective of their capacity to provide access to affordable medicines. The two types of licences are evaluated also as to their capacity to grant access to intellectual property rights and to data protected either through regulatory exclusivities or as trade secrets or know-how. The contracts concluded by the Medicines Patent Pool are used as source data for emerging best practices in voluntary licensing.
As a matter of novelty, licences are also discussed in relation to competition rules. On the one hand, restrictive licensing practices, while necessary in order to tailor access to certain territories or fields, must be compliant with competition rules, which limit the freedom of contract. On the other hand, it is also evaluated the extent to which compulsory licences can address excessive prices of medicines on grounds of anti-competitive behaviour and, more generally, the excessive pricing doctrine under competition law. EU law is used as case study jurisdiction.
Therefore, the research also evaluates the intellectual property - competition law interplay in the TRIPS Agreement from the perspective of how it can be tailored in national legislations to enhance access to affordable medicines.
13 mai 2025